Baldwin Wealth Partners’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNLX
GGHC
PGM
GIM
FAM
ACH
PA
GG
PCM
Baldwin Wealth Partners's RNLX Position: Q3 2021 in Review
Baldwin Wealth Partners sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2021, closing a stake of 1,000 shares — an estimated $31K sold.
Baldwin Wealth Partners first reported a position in RNLX in Q1 2021 and held it in 2 quarters. The position peaked at $31K in Q2 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q3 2021.
- Baldwin Wealth Partners reported no remaining Renalytix plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
- Baldwin Wealth Partners sold 1,000 Renalytix plc American Depositary Shares shares in Q3 2021, an estimated $31K.
- Baldwin Wealth Partners first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 2 quarters.
- Baldwin Wealth Partners's Renalytix plc American Depositary Shares position peaked at $31K in Q2 2021.
- 31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2021.
Based on Baldwin Wealth Partners's 13F filing for Q3 2021, filed 27 Oct 2021.